DGAP-News

PAION AG: RECRUITMENT OF PHASE II/III STUDY WITH SHORT-ACTING ANAESTHETIC/SEDATIVE REMIMAZOLAM (ONO'S DEVELOPMENT CODE: ONO-2745) IN JAPAN IS COMPLETED - Seite 2

- Procedural sedation (e.g. colonoscopies, Phase IIb completed: PAION)

- General anaesthesia (Phase II/III ongoing: ONO; Phase II in
preparation: PAION)

- ICU sedation (Phase II ongoing: ONO)

Remimazolam is available for licensing outside Japan and China, where the
compound is partnered with Ono Pharmaceutical and Yichang Humanwell,
respectively.

Contact
Ralf Penner
Director Investor Relations / Public Relations
PAION AG
Martinstrasse 10-12, 52062 Aachen - Germany
Phone [phone]
E-mail [e-mail]
http://www.paion.com

Disclaimer:
This release contains certain forward-looking statements concerning the
future business of PAION AG. These forward-looking statements contained
herein are based on the current expectations, estimates and projections of
PAION AG's management as of the date of this release. They are subject to a
number of assumptions and involve known and unknown risks, uncertainties
and other factors. Should actual conditions differ from the Company's
assumptions, actual results and actions may differ materially from any
future results and developments expressed or implied by such
forward-looking statements. Considering the risks, uncertainties and other
factors involved, recipients should not rely unreasonably upon these
forward-looking statements. PAION AG has no obligation to periodically
update any such forward-looking statements to reflect future events or
developments.



End of Corporate News

---------------------------------------------------------------------

08.05.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language: English
Company: PAION AG
Martinstr. 10-12
52062 Aachen
Germany
Phone: [phone]
Fax: [phone]
E-mail: [e-mail]
Internet: www.paion.com
ISIN: DE000A0B65S3
WKN: A0B65S
Listed: Regulierter Markt in Frankfurt (General Standard);
Freiverkehr in Berlin, Düsseldorf, Hamburg, München,
Stuttgart


End of News DGAP News-Service
---------------------------------------------------------------------
210279 08.05.2013